Guideline for the diagnosis and treatment of hemophilia for Chinese children (2024)

Title: Guideline for the diagnosis and treatment of hemophilia for Chinese children (2024)
Edition: Original
Classification: Standard guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: The target users of the guideline are hematologists, primary care physicians who are involved in the clinical practice of pediatric hemophilia.
Evidence classification method: GRADE
Development unit: Beijing Children’s Hospital, Capital Medical University
Registration time: 2024-03-11
Registration number: PREPARE-2024CN373
Purpose of the guideline: The purpose of the guideline is to provide an evidence-based basis for the clinical diagnosis and treatment of hemophilia in children and to provide evidence-based support in physicians' clinical practice.